Abstract:Aims Haploinsufficiency of the chromo-domain protein CHD7 underlies most cases of CHARGE syndrome, a multisystem birth defect including congenital heart malformation. Context specific roles for CHD7 in various stem, progenitor and differentiated cell lineages have been reported. Previously we showed severe defects when Chd7 is absent from cardiopharyngeal mesoderm (CPM). Here we investigate altered gene expression in the CPM and identify specific CHD7-bound target genes with known roles in the morphogenesis of affected structures. Methods and results We generated conditional KO of Chd7 in CPM and analysed cardiac progenitor cells using transcriptomic and epigenomic analyses, in vivo expression analysis, and bioinformatic comparisons with existing datasets. We show CHD7 is required for correct expression of several genes established as major players in cardiac development, especially within the second heart field (SHF). We identified CHD7 binding sites in cardiac progenitor cells and found strong association with histone marks suggestive of dynamically regulated enhancers during the mesodermal to cardiac progenitor transition of mESC differentiation. Moreover, CHD7 shares a subset of its target sites with ISL1, a pioneer transcription factor in the cardiogenic gene regulatory network, including one enhancer modulating Fgf10 expression in SHF progenitor cells versus differentiating cardiomyocytes. Conclusion We show that CHD7 interacts with ISL1, binds ISL1-regulated cardiac enhancers and modulates gene expression across the mesodermal heart fields during cardiac morphogenesis. Translational Perspective CHD7 is a chromatin remodeller haploinsufficient in CHARGE syndrome and implicated in autism spectrum disorder and various cancers. Heart defects in the syndrome are recapitulated by murine loss-of-function in two linages, neural crest and cardiopharyngeal mesoderm (CPM). CHD7 regulates vital cardiogenic genes via binding predominantly to enhancers distant from the target gene at sites often shared with the pioneer transcription factor ISL1. CHD7 bound enhancer elements show highly dynamic switching of histone modifications during the mesodermal to cardiac progenitor cell transition. Thus, manipulation of CHD7 activity may assist in directed differentiation of distinct cardiovascular progenitors for use in regenerative/repair therapeutics.

CHD7 Represses the Retinoic Acid Synthesis Enzyme ALDH1A3 During Inner Ear Development.

CHD7 regulates otic lineage differentiation and deafness gene expression in human inner ear organoids

CHD7 Promotes Neural Progenitor Differentiation in Embryonic Stem Cells Via Altered Chromatin Accessibility and Nascent Gene Expression.

CHD7 regulates otic lineage specification and hair cell differentiation in human inner ear organoids

CHD7 regulates craniofacial cartilage development via controlling HTR2B expression

CHARGE syndrome-associated CHD7 acts at ISL1-regulated enhancers to modulate second heart field gene expression

The mutation in Chd7 causes misexpression of Bmp4 and developmental defects in telencephalic midline.

Versatile Roles of the Chromatin Remodeler CHD7 during Brain Development and Disease.

Chromatin remodeller Chd7 is developmentally regulated in the neural crest by tissue-specific transcription factors

Chd7 cooperates with Sox10 and regulates the onset of CNS myelination and remyelination

Chd7 is Indispensable for Mammalian Brain Development Through Activation of a Neuronal Differentiation Programme

Chromatin remodeling by the CHD7 protein is impaired by mutations that cause human developmental disorders

Chd7 Is Critical for Early T-Cell Development and Thymus Organogenesis in Zebrafish.

Sema3E is required for migration of cranial neural crest cells in zebrafish: Implications for the pathogenesis of CHARGE syndrome

Deletion of the chd7 Hinders Oligodendrocyte Progenitor Cell Development and Myelination in Zebrafish

CHD7 and SOX2 act in a common gene regulatory network during mammalian semicircular canal and cochlear development

Establishment of an Induced Pluripotent Stem Cell Line from a Patient with CHARGE Syndrome Carrying a CHD7 (p.l1151gfs*17) Mutation

Eyes on CHARGE syndrome: Roles of CHD7 in ocular development

CHD7 Regulates Bone-Fat Balance by Suppressing PPAR-γ Signaling

Morphological and sensorimotor phenotypes in a zebrafish CHARGE syndrome model are domain-dependent

Phenotypic Spectrum of Idiopathic Hypogonadotropic Hypogonadism Patients with CHD7 Variants from a Large Chinese Cohort